Vertiflex Procedure
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
For more information on our portfolio of pain management product offerings, visit: https://www.linkedin.com/showcase/boston-scientific-pain-management
Innovation and Technology Adoption The company utilizes advanced tech stacks such as PTC Creo, Google Cloud, and Elastic Stack, indicating a strong focus on leveraging modern technology for product development and operational efficiency, presenting an opportunity for partnerships in digital solutions and software integration.
Growth and Market Presence With recent revenue of over $5.2 billion and participation in prominent medical conferences like Heart Rhythm Society and Strategic Decisions Conference, the company is expanding its market footprint, offering potential for sales of innovative medical devices and surgical solutions.
Regulatory and Legal Environment Recent securities fraud lawsuits and legal challenges involving Boston Scientific suggest a dynamic and potentially risky environment, highlighting opportunities for compliance solutions, legal consulting, or investor relations support to mitigate legal risks.
Competitive Landscape Facing competition from Johnson & Johnson and Verve Medical in key procedures like pulsed field ablation and hypertension treatments, the company is actively engaged in product innovation, which might present cross-selling opportunities for complementary or alternative devices in cardiology and vascular markets.
Customer and Market Trends Participating in industry-specific events and sharing data on cardiac devices indicates a focus on market trends and customer engagement, offering prospects for targeted marketing, thought leadership content, or sales initiatives aligned with advancing cardiology and pain management solutions.
Vertiflex Procedure uses 8 technology products and services including PTC Creo, Fastly, cdnjs, and more. Explore Vertiflex Procedure's tech stack below.
| Vertiflex Procedure Email Formats | Percentage |
| FLast@vertiflexspine.com | 76% |
| Last@vertiflexspine.com | 21% |
| First.Last@vertiflexspine.com | 3% |
| FLast@vertiflex.com | 100% |
| First.Last@bostonscientific.com | 76% |
| FLast@bostonscientific.com | 9% |
| First_Last@bostonscientific.com | 8% |
| First@bostonscientific.com | 7% |
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
For more information on our portfolio of pain management product offerings, visit: https://www.linkedin.com/showcase/boston-scientific-pain-management
Vertiflex Procedure has raised a total of $4.3B of funding over 1 rounds. Their latest funding round was raised on Feb 25, 2019 in the amount of $4.3Bas a debt offering.
Vertiflex Procedure's revenue is estimated to be in the range of $1M$10M
Vertiflex Procedure has raised a total of $4.3B of funding over 1 rounds. Their latest funding round was raised on Feb 25, 2019 in the amount of $4.3Bas a debt offering.
Vertiflex Procedure's revenue is estimated to be in the range of $1M$10M